Charting a Path of Innovation and
Excellence: Our Values at VelZen Pharma.
Charting a Path of Innovation and
Excellence: Our Values at VelZen Pharma.
Meet Our Key Team
Discover the driving force behind VelZen Pharma's success: a dedicated team of experts committed to excellence, innovation, and client satisfaction.

Dr. KIRAN VELAVENI
Managing Director & CEO

Dr. S. VERMA
Global Technical Advisor

Director
.
- Seasoned pharmaceutical professional, with over 15 years of experience in handling with multiple Clinical Research Organizations (CROs) to ensure good quality worldwide regulatory submissions.
- She has efficiently managed working in different time zones and worked successfully on defining product strategies based on ICH and FDA guidelines across a broad range of therapeutic categories.
- She has efficiently worked on several regulatory queries wrt to M5, have expertise to analyse and predict the statistical calculations to have a way forward for submission studies.
- Her experience with pharma companies enabled her to coordinate with various clients as part of their collaborations with associated companies, and thus enthusiastic in take part in business development.
- Result-driven expertise in identifying study design, protocol, BE study monitoring and Module 5.

Ramesh Allada
Vise President

Pravalika Dasari
BD&PM Head

Prakash D Bharat
General Manager
Prakash D Bharat is a senior pharmaceutical professional with over 25 years of experience in Analytical Research and Development. He holds a Master’s degree (M.Sc.) in Organic Chemistry.
His core expertise includes analytical method development, verification, validation, routine analysis, stability testing, analytical documentation, and method transfer for solid oral, injectable, ophthalmic dosage forms, APIs, and CRO products.
He has worked extensively for regulatory markets including the US, Europe, Brazil, Japan, Rest of World (ROW), and domestic markets.
He has held key roles in analytical development at leading Indian pharmaceutical R&D organizations including Wockhardt Research Centre, Torrent Research Centre, Laxai Life Sciences, Jubilant Life Sciences, and Laurus Labs Ltd, where he has been responsible for developing analytical methods for dosage forms and APIs to meet regulatory submissions requirement.
Key competencies: